HSK39004 Inhalation Suspension

DRUG3 trials

Sponsors

Haisco Pharmaceutical Group Co., Ltd.

Conditions

COPD (Chronic Obstructive Pulmonary Disease)COPD Patients

Phase 2

A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD Patients

Active, not recruitingNCT07331402

Haisco Pharmaceutical Group Co., Ltd.COPD Patients

Start: 2025-07-28End: 2026-08-30Target: 12Updated: 2026-01-09

Phase 3

Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPD

Not yet recruitingNCT07634367

Haisco Pharmaceutical Group Co., Ltd.COPD (Chronic Obstructive Pulmonary Disease)

Start: 2026-07-10End: 2027-12-24Target: 300Updated: 2026-06-08

A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD

Not yet recruitingNCT07658339

Haisco Pharmaceutical Group Co., Ltd.COPD (Chronic Obstructive Pulmonary Disease)

Start: 2026-07-11End: 2027-06-11Target: 387Updated: 2026-06-22